A Dose-escalation Study to Investigate Safety and Toleration of OZ439

Summary

A randomised, placebo-controlled, dose-escalation study to investigate safety and toleration of OZ439 OD for 3 days to healthy male and female volunteers. The study aims: * To determine the safety and tolerability of ascending doses of OZ439 OD for three days. * To assess pharmacokinetic parameters of ascending doses of OZ439 given OD. * To identify the maximum tolerated dose of OZ439 administered.

Timeline

Start

2012-11

Primary completion

2013-02

Completion

2013-02

Drugs

Indications